PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
Clinical trial NCT00439673 · COMPLETED
Trial details
- NCT number
- NCT00439673
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2010-07-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.